DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20184937

Assessment of the level of serum uric acid in patients of pre-eclampsia and their comparison with levels in normotensive pregnancy

Hemant G. Deshpande, Chandrakant S. Madkar, Madhukar Shinde, Vilisha S. Kothari

Abstract


Background: Pre-eclampsia is one of the major causes of maternal and perinatal morbidity and mortality. There are various parameters to evaluate pre-eclampsia. S.uric acid levels is one of the important biochemical markers in pre-eclampsia. The objective of current study is to compare the levels of S.uric acid in pre-eclamptic patients and normotensive patients.

Methods: A total of 256 antenatal patients, consisting of two groups, 128 patients in each group diagnosed with pre-eclampsia (either earlier or during examination) and 128 control antenatal patients in their third trimester were considered. Both the groups were compared in relation to age, parity, socio economic status and geographical variations. Blood sample (venous blood) of about 5ml was drawn from the ante cubital vein of the patient under all aseptic precautions to estimate S.uric acid levels.

Results: The observation of present study shows that the level of serum uric acid is significantly higher in the cases of pre-eclampsia. The value of S.uric acid increases with the severity of pre-eclampsia.

Conclusions: It is concluded from this study that high levels of uric acid are found in the serum of pre-eclamptic cases as compared to normotensive cases of the study population. The levels of uric acid are higher in severe cases as compared to the levels in mild and moderate cases.


Keywords


Hypertensive disorders in pregnancy, Maternal and perinatal morbidity and mortality, Pre-eclampsia, S.uric acid levels

Full Text:

PDF

References


Martin JA, Hamilton BE, Ventura SJ, Menacker F, Park MM, Sutton PD. Births: final data for 2000. USA: National Vital Statistics; 2002.

Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol. 2003;101(2):289-96.

Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, et al. Calcium for preeclampsia prevention study group. Pregnancy outcomes in healthy nulliparas who developed hypertension. Obstet Gynecol. 2000;95(1):24-8.

Vatten LJ, Skjærven R. Is pre‐eclampsia more than one disease?. BJOG. 2004;111(4):298-302.

Maternal Mortality, World Health Organization fact sheet November 2016. Available at: http://apps.who.int/iris/bitstream/10665/112318/1/WHO_RHR_14.06_eng.pdf.

Cunnighham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, Spong CY. Hypertensive disorder contributed by Dr John Houth. In: Williams Obstetrics. 25th ed. McGraw Hill Education; 2018:40:1569.

Bainbridge SA, Roberts JM. Uric Acid as a Pathogenic Factor in Preeclampsia. Placenta. 2008;29(Suppl A):S67-72.

Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183-90.

Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41:1287-93.

Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, et al. Effect of insulin on uric acid excretion in humans. Am J Physiol. 1995;268:E1-5.

Carter J, Child A. Serum uric acid levels in normal pregnancy. Aust N Z J Obstet Gynaecol. 1989;29:313-4.

Powers RW, Bodnar LM, Ness RB, Cooper KM, Gallaher MJ, Frank MP, et al. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol. 2006;194:160-e1.

Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, et al. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension. 2005;46:1263-9.

Gallery ED, Hunyor SN, Gyory AZ. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Q J Med. 1979;48:593-602.

Hypertension in Pregnancy. National Institute for Health and Care Excellence Pathways June 2017. Available at: https://www.ncbi.nlm.nih.gov/books/NBK11822/.

Kang DH, Finch J, Nakagawa T, Karumanchi SA, Kanellsi J, Granger J, et al. Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertension. 2004;22:229-35.

Verma V, Sogani S, Sarkar PD. Comparative study of serum calcium and magnesium in pre-eclamptic pregnancies in third trimester and its comparison with healthy normotensive nonpregnant and pregnant women and to evaluate their role in pregnancy-induced hypertension. MGM J Med Sci. 2015;2(3):137-41.

Sirajwala HB, Sharma D, Agravatt AM. A study of serum total calcium and uric acid levels in preeclampsia. Indian J Basic Appl Medi Res. 2013;1(3):50-6.

Thangaratinam S, Ismail KM, Sharp S, Coomarasamy A, Khan KS. Accuracy of serum uric acid in predicting complications of pre‐eclampsia: a systematic review. BJOG. 2006;113(4):369-78.